2 July 2013
How long should scientists stay at the bench, asks Derek Lowe. How long is a piece of string?
Knowing a drug’s exact biochemistry has never been a prerequisite for approval, says Derek Lowe, and nor should it be
30 April 2013
A can-do attitude and some lateral thinking can save time and money when it comes to exotic apparatus, says Derek Lowe
2 April 2013
Derek Lowe asks (with some trepidation): do drug companies need scientists at the top?
6 March 2013
It’s more a research problem, than a commercial one, says Derek Lowe
25 January 2013
Derek Lowe investigates the long running tradition of naming reactions after their inventors
2 January 2013
How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe
27 November 2012
The pharma industry should be more open with its trial data, says Derek Lowe
31 October 2012
Derek Lowe examines an alternative funding model for pharmaceutical research
26 September 2012
There might be a better way to interview new starters, suggests Derek Lowe
Regularly updated and packed full of articles, podcasts and videos, there is no better way to keep in touch with the chemical sciences.
Published by the Royal Society of Chemistry. Registered charity number: 207890
Site powered by Webvision